Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 20 IN PLASTIC CONTAINER versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 20 IN PLASTIC CONTAINER versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
MANNITOL 20% IN PLASTIC CONTAINER vs OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolality, drawing water from intracellular compartments into extracellular fluid. In the kidneys, it is freely filtered at the glomerulus but minimally reabsorbed, increasing tubular fluid osmolality and reducing water reabsorption, thereby promoting diuresis. It also reduces cerebral edema by creating an osmotic gradient that draws water from brain tissue into plasma.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal tubular osmotic pressure, thereby inhibiting water reabsorption and promoting diuresis.
Intravenous: 50-100 g (250-500 mL of 20% solution) over 30-60 minutes; may repeat every 6-8 hours as needed. For cerebral edema: 1-2 g/kg IV over 30-60 minutes.
0.25-1 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours if needed.
None Documented
None Documented
Terminal elimination half-life: 0.25–1.7 hours in normal renal function; prolonged in renal impairment.
Terminal elimination half-life is 0.25–1.5 hours in normal renal function; prolonged to 4–6 hours with anuria or oliguria. Clinically, osmotic diuresis lasts as long as urine output sustains concentration.
Renal: >90% as unchanged drug. Biliary/fecal: negligible.
Primarily renal (90-100% unchanged) via glomerular filtration; <3% metabolized in liver; minimal biliary/fecal excretion.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic